-
Bayern sign Morocco midfielder Saibari on five-year deal
-
Messi returns 'home' to lead Argentina World Cup charge in Miami
-
Hope fades, hunger sets in a week after Venezuela quakes
-
England skipper Sciver-Brunt 'threw everything' at World Cup semi-final return
-
Noosha Aubel: 10 km/h for residents – Potsdam’s approach to potholes: indifference or incompetence?
-
Stocks mixed with eyes on US Fed
-
Bayern to host Stuttgart in Bundesliga season opener
-
Trial begins for suspected mastermind of Malta journalist killing
-
US Fed chair says committed to combatting 'too high' prices
-
Traditionalist Catholic society defies Vatican by consecrating new bishops
-
Portugal braces for high temperatures in new heatwave
-
World number ones Sinner, Sabalenka into Wimbledon third round
-
Trump upbeat as US, Iran hold indirect talks in Qatar
-
Sony to stop releasing PlayStation games on discs
-
Sinner sinks Borges to step up Wimbledon title defence
-
All-white and lavender: Wimbledon hunts drought-resistant flowers
-
Thomas targets yellow in Tour team time-trial
-
Inter Milan laud veteran Mkhitaryan after deal extension
-
Bike - or even walk: World Cup fans improvise to reach NY venue
-
Vaughan calls for England coaching clear-out after Stokes exit
-
Swedish court orders Google pay nearly $2 bn for favouring its price comparisons
-
Sony says to stop releasing PlayStation games on discs
-
England breaks record for warmest June: Met Office
-
Sabalenka sets up Wimbledon third-round clash with Ostapenko
-
Stocks drop with eyes on US Fed
-
Planned 1.7 million satellites 'devastating' for astronomy: study
-
Barca have bid for Atletico's Alvarez: president Laporta
-
Trump defends earning more than $1bn on crypto
-
'Smart' and 'very rational'? Iran's new leaders post-Ali Khamenei
-
Sciver-Brunt fit for England's T20 World Cup semi-final
-
Bordeaux-Begles handed favourable draw in Champions Cup defence
-
Key challenges for Laporta in second Barca term
-
'Thought they'd never be caught': The strike that killed Iran's Khamenei
-
Canada to join Eurovision Song Contest
-
Djokovic, Sinner hope for easier ride after Wimbledon scares
-
Swedish court orders Google pay $1.46 bn for favouring its price comparisons
-
Injured Serena's Wimbledon doubles bid with sister Venus in doubt
-
German FA headquarters searched in Euro 2024 graft probe
-
European stocks mostly drop with eyes on US Fed
-
Village People singer Victor Willis dies at 74
-
Genesio replaces Beye as Marseille boss
-
Thousands rush to get tickets for Bayeux Tapestry's UK show
-
Catholic society defies Vatican again by ordaining new bishops
-
Chinese firm sells hyper-real, 'always loyal' humanoid robots
-
Breakaway Catholic society defies Vatican again by ordaining bishops
-
World's oceans break June heat record: EU monitor
-
Venezuelans search, suffer one week after deadly quakes
-
China imposes 'national security' rules on overseas investments
-
Asian stocks mostly up as traders eye crucial US jobs data
-
'Nothing left except death': Myanmar families grieve huge war toll
Chinese medical portal censored after doubting herbal 'Covid remedy'
A popular Chinese medical information site has been censored by authorities for "violation of relevant laws and regulations", months after its criticism of a government-backed herbal Covid-19 treatment sent shares in a pharmaceutical giant tumbling.
DXY, which counts tech giant Tencent among its investors and runs a host of health-related services, previously questioned the value of Lianhua Qingwen, a herbal remedy marketed for fever and sore throats, as a Covid-19 treatment.
China approved the concoction -- made up of ingredients like honeysuckle and apricot seeds -- as a Covid-19 treatment in 2020, and it was distributed to Shanghai residents during the city's outbreak this year.
DXY's article was part of a wave of reports that caused shares in Lianhua Qingwen's producer -- one of China's largest traditional medicine companies -- to plunge.
The website has now been banned from posting on at least five of its Weibo social media accounts, with a notice at the top of its official page saying that due to "violation of relevant laws and regulations, this user is currently prohibited from posting".
DXY's official WeChat accounts, which typically publish multiple articles a day on medical topics, have not been updated since Monday.
The Weibo notice did not specify which regulations had been violated by DXY, which did not immediately respond to AFP's request for comment.
The Chinese government has increasingly promoted traditional medicine at home and abroad in recent years, often with nationalistic undertones.
DXY's coverage prompted criticism that it was targeting traditional Chinese medicine (TCM) in order to promote Western pharmaceuticals.
The United States and other countries have warned there is no evidence Lianhua Qingwen works to prevent or cure Covid-19, even as it has increasingly been promoted by government authorities in China and Hong Kong.
The US Food and Drug Administration has said it has not approved Lianhua Qingwen and that coronavirus-related claims about it were "not supported by competent and reliable scientific evidence".
Beijing issued its first white paper on TCM in 2016, laying out plans to build medicine centres and dispatch practitioners to developing countries in Africa and Southeast Asia.
President Xi Jinping has described TCM as a "treasure of Chinese civilisation" and has said that it should be given as much weight as other treatments.
Beijing's National Health Commission has also dispatched TCM practitioners as part of its medical reinforcement teams sent to fight Covid-19 outbreaks across the country.
E.Schubert--BTB